As a valued subscriber to the wealth of resources published by Relias Media, we are sending this reminder that your new issue is now available online. The articles in this issue are listed below:
Infection preventionists are preparing for an unknown but widely predicted possibility this fall and winter: a large second wave of SARS-CoV-2 (COVID-19) hitting hospitals amid the 2020-2021 influenza season.
Although the pandemic of SARS-CoV-2 (COVID-19) has been relatively benign in children compared to adults, there is growing concern about an emerging syndrome that causes severe, sometimes fatal, outcomes in pediatric patients.
A highly experienced nurse knew to remain calm and turn her healing power inward as she fought COVID-19 in patient isolation for six long days in a hospital.
Trying to strike a balance epidemiologically, and perhaps politically, the Centers for Disease Control and Prevention has issued guidelines for people wanting to leave home and attend gatherings as COVID-19 cases generally have plateaued nationally.
The Centers for Disease Control and Prevention has updated infection control guidelines for COVID-19 in dental settings, including new information on facility and equipment considerations and using test-based strategies to inform patient care.
Help us deliver the content important to you! Please five minutes to complete our annual user survey and be entered to win a yearlong subscription to Relias Media's entire newsletter catalog: https://bit.ly/2VXU4Zd
Relias Media is offering free, unlimited access to our COVID-19 related content to help healthcare professionals stay up to date and respond to the pandemic. Click here to access our COVID-19 resource page!
Financial Disclosure: Peer Reviewer Patrick Joseph, MD, reports that he is a consultant for Genomic Health, Siemens, and CareDx. Senior Writer Gary Evans, Editor Jason Schneider, Executive Editor Shelly Mark, Nurse Planner Patti Grant, RN, BSN, MS, CIC, and Editorial Group Manager Leslie Coplin report no consultant, stockholder, speaker’s bureau, research, or other financial relationships with companies having ties to this field of study
